Plante Moran Financial Advisors’s Mereo BioPharma MREO Stock Holding History

Plante Moran Financial Advisors’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-48	Closed	-$173	–	900
2024 Q2	$173	Hold	48	–	–	﹤0.01%	761
2024 Q1	$158	Hold	48	–	–	﹤0.01%	820
2023 Q4	$111	Hold	48	–	–	﹤0.01%	798
2023 Q3	$62	Hold	48	–	–	﹤0.01%	747
2023 Q2	$63	Hold	48	–	–	﹤0.01%	777
2023 Q1	$34	Hold	48	–	–	﹤0.01%	782
2022 Q4	$36	Hold	48	–	–	﹤0.01%	847
2022 Q3	$0	Hold	48	–	–	﹤0.01%	996
2022 Q2	$0	Hold	48	–	–	﹤0.01%	1024
2022 Q1	$0	Hold	48	–	–	﹤0.01%	930
2021 Q4	$0	Hold	48	–	–	﹤0.01%	1064
2021 Q3	$0	Hold	48	–	–	﹤0.01%	986
2021 Q2	$0	Hold	48	–	–	﹤0.01%	1030
2021 Q1	$0	Hold	48	–	–	﹤0.01%	1077
2020 Q4	$0	Hold	48	–	–	﹤0.01%	945
2020 Q3	$0	Hold	48	–	–	﹤0.01%	880
2020 Q2	$0	Hold	48	–	–	﹤0.01%	819
2020 Q1	$0	Hold	48	–	–	﹤0.01%	801
2019 Q4	$0	Hold	48	–	–	﹤0.01%	841
2019 Q3	$0	Hold	48	–	–	﹤0.01%	890
2019 Q2	$0	Buy	+48	New	+$210	﹤0.01%	823

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Plante Moran Financial Advisors's MREO Position: Q3 2024 in Review

Plante Moran Financial Advisors sold out of Mereo BioPharma (MREO) in Q3 2024, closing a stake of 48 shares — an estimated $173 sold.

Plante Moran Financial Advisors first reported a position in MREO in Q2 2019 and held it in 21 quarters. The position peaked at $173 in Q2 2024. 77 funds tracked by Wall St. Rank hold MREO as of Q3 2024.

Plante Moran Financial Advisors reported no remaining Mereo BioPharma position as of Q3 2024 after selling out during the quarter.
Plante Moran Financial Advisors sold 48 Mereo BioPharma shares in Q3 2024, an estimated $173.
Plante Moran Financial Advisors first reported a position in Mereo BioPharma in Q2 2019 and held it in 21 quarters.
Plante Moran Financial Advisors's Mereo BioPharma position peaked at $173 in Q2 2024.
77 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2024.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.